Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Fr J Urol ; 34(7-8): 102657, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38821382

RESUMO

INTRODUCTION: To describe the perioperative outcomes in patients treated with radical nephrectomy with cava thrombectomy at all thrombi levels using a multidisciplinary approach, with or without extracorporeal circulation (ECC), and to identify factors associated with perioperative morbidity. METHODS: We retrospectively identified 42 patients who were diagnosed with renal cell carcinoma (RCC) and a vena cava thrombus and treated with radical nephrectomy and cava thrombectomy by a double surgical team at Lyon University Hospital from 2008 through 2021. The surgeons operated in the cardiothoracic operating theater to proceed with median sternotomy or ECC, if necessary. The primary endpoint of this study was perioperative morbidity and mortality assessed using the Clavien-Dindo scale. Complications were recorded until 90 days after surgery, and those classified as grade IIIa or higher were considered high-grade complications. RESULTS: Overall, 32 (76%) patients required ECC. No intraoperative mortality occurred; however, two patients (5%) died within 30 days. Complications occurred within 30 days in 30 patients (72%), with severe complications observed in 10 patients (24%). No further complications occurred between 30 and 90 days. Multivariate analysis revealed that age, thrombus level, ECC, American Society of Anesthesiologists physical status, symptoms, and metastasis at presentation were not significantly associated with high-grade complications (P>0.05). CONCLUSIONS: Multidisciplinary approach is essential and frequent use of ECC, when achieved by a trained team, may facilitate surgery, and is associated with low perioperative morbidity, especially for patients with high-level thrombi. LEVEL OF EVIDENCE: IV.


Assuntos
Carcinoma de Células Renais , Neoplasias Renais , Nefrectomia , Trombectomia , Veia Cava Inferior , Humanos , Trombectomia/efeitos adversos , Trombectomia/métodos , Carcinoma de Células Renais/cirurgia , Carcinoma de Células Renais/mortalidade , Carcinoma de Células Renais/patologia , Nefrectomia/métodos , Estudos Retrospectivos , Masculino , Neoplasias Renais/cirurgia , Neoplasias Renais/patologia , Neoplasias Renais/mortalidade , Feminino , Pessoa de Meia-Idade , Idoso , Resultado do Tratamento , Veia Cava Inferior/cirurgia , Veia Cava Inferior/patologia , Trombose Venosa/cirurgia , Complicações Pós-Operatórias/etiologia , Células Neoplásicas Circulantes/patologia , Equipe de Assistência ao Paciente
2.
Nephrol Ther ; 19(6): 507-519, 2023 11 02.
Artigo em Francês | MEDLINE | ID: mdl-37915199

RESUMO

Physical activity (PA), has a proven effect on overall health. The study assessed the difference in glomerular filtration rate (GFR) over one year in non-dialysis renal failure patients between those who practiced exercise (P) and those who did not (NP). Patients were categorised as P or not P using the Global Physical Activity Questionnaire (GPAQ2), completed by telephone, at inclusion and at 12 months. Among the 259 patients included, 195 (75.3%) practiced a PA and 64 (24.7%) did not practiced. There was no significant difference in the slope of GFR decline from inclusion to month 12 between the two groups, p = 0.4107. Only the type of kidney seemed to be significantly associated with the slope of GFR decline over the 12 months (p = 0.0039). These results may be explained by a follow-up time too short to identify an effect of behavioural change on the progression of kidney disease.


L'activité physique (AP) a un effet démontré sur l'état de santé global. L'étude évaluait, chez des patients insuffisants rénaux non dialysés, la différence, sur un an, de l'évolution du débit de filtration glomérulaire (eDFG) entre ceux pratiquant une AP (P) et ceux n'en pratiquant pas (NP). Les patients ont été classés comme P ou NP grâce au questionnaire d'AP GPAQ2, passé par téléphone, à l'inclusion et à 12 mois. Parmi les 259 patients inclus, 195 (75,3 %) pratiquaient une AP et 64 (24,7 %) n'en pratiquaient pas. Il n'existe pas de différence significative sur la pente de décroissance du eDFG entre l'inclusion et le 12e mois (p = 0,4107). Le type de néphropathie semblerait associé significativement à cette pente de décroissance au cours des 12 mois (p = 0,0039). Ces résultats peuvent s'expliquer par une durée de suivi trop courte pour mettre en évidence un effet de la modification du comportement sur l'évolution de la maladie rénale.


Assuntos
Falência Renal Crônica , Insuficiência Renal Crônica , Humanos , Falência Renal Crônica/terapia , Falência Renal Crônica/complicações , Insuficiência Renal Crônica/terapia , Insuficiência Renal Crônica/complicações , Rim , Taxa de Filtração Glomerular , Exercício Físico , Progressão da Doença
3.
J Clin Med ; 12(13)2023 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-37445244

RESUMO

The base of the tongue (BOT) is the second most common site for squamous cell carcinoma (SCC) in the oropharynx. There are currently no clear guidelines for the management of BOT SCC. Our main objective was to compare the oncological outcomes of two minimally invasive approaches, transoral laser microsurgery (TLM) and transoral robot-assisted surgery (TORS). This was a retrospective French GETTEC (Groupe d'Études des Tumeurs de la Tête et du Cou) multicenter study of patients with BOT SCC removed surgically either by TLM or TORS between 2005 and 2021. The study group included 16 patients treated by TLM and 38 by TORS, with median follow-up times of 14.4 and 37.2 months, respectively. The overall survival (OS) rates at 2 and 3 years were 67% in the TLM group and 90% at 2 years and 86% at 3 years in the TORS group (p = 0.42, p = 0.20). There was no significant difference in recurrence-free survival (RFS) between the two techniques after 2 and 3 years. The tumors removed by TORS were significantly larger. Operative times were significantly shorter in the TLM group. There were no differences in feeding resumption; none of the patients in the TLM group required a tracheotomy. Postoperative hemorrhagic complication rates were similar in the two groups (12% for TLM and 13% for TORS). Both TORS and TLM showed encouraging oncological, functional, and safety results in BOT SCC even in recurrence or second primary cancer patients, without a technique being found superior in terms of OS or RFS. Tumors removed by TORS were larger without an increase in postoperative bleeding, extending the possibilities of transoral treatment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA